Core Scientific Shares Up 0.98% to $15.99
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy CORZ?
Mixed options sentiment in Core Scientific, Inc (CORZ), with shares up 16c, or 0.98%, near $15.99. Options volume roughly in line with average with 134k contracts traded and calls leading puts for a put/call ratio of 0.41, compared to a typical level near 0.52. Implied volatility (IV30) dropped 2.13 near 86.33,and below the 52wk median, suggesting an expected daily move of $0.87. Put-call skew steepened, indicating increased demand for downside protection, following an upgrade to Buy at Needham.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CORZ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CORZ
Wall Street analysts forecast CORZ stock price to rise
15 Analyst Rating
14 Buy
1 Hold
0 Sell
Strong Buy
Current: 15.160
Low
19.94
Averages
27.46
High
40.00
Current: 15.160
Low
19.94
Averages
27.46
High
40.00
About CORZ
Core Scientific, Inc. provides digital infrastructure for high-density colocation services and digital asset mining. The Company operates dedicated, purpose-built facilities for digital asset mining and is a provider of digital infrastructure, software solutions and services to its third-party customers. Its Digital Asset Self-Mining segment consists of digital asset mining for its own account. Its Digital Asset Hosted Mining segment consists of its digital infrastructure and third-party hosting services for digital asset mining. Its Colocation segment consists of providing high-density colocation services to third parties for graphics processing units (GPU)-based high-performance computing (HPC) operations. It employs its own large fleet of computers (miners) to earn digital assets for its own account and to provide hosting services for large digital asset-mining customers, and it is in the process of allocating and converting a significant portion of its 10 facilities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CORE SCIENTIFIC INC - TERM LOAN FACILITY EXPIRES 364 DAYS POST-CLOSING DATE - SEC FILING
- Core Scientific Loan Facility: The Core Scientific loan facility has matured 364 days after its closing date.
- SEC Filing: This development has been documented in a filing with the Securities and Exchange Commission (SEC).
See More
CORE SCIENTIFIC INC SECURES $500 MILLION SENIOR LOAN FACILITY THROUGH CREDIT AGREEMENT - SEC FILING
Loan Facility Announcement: Core Scientific has secured a senior secured loan facility amounting to $500 million.
Purpose of the Loan: The loan is intended to provide financial support for the company's operations and growth initiatives.
See More
CORE SCIENTIFIC INC SECURES LOAN FACILITY CREDIT AGREEMENT WITH MORGAN STANLEY SENIOR FUNDING ON MARCH 4 - SEC FILING
Core Scientific's Loan Facility: Core Scientific has entered into a loan facility agreement with Morgan Stanley Senior Funding to secure additional funding.
Financial Strategy: This agreement is part of Core Scientific's strategy to enhance its financial position and support its operations amidst market challenges.
See More
Core Scientific Secures $500 Million Loan Facility to Expand Infrastructure
- Liquidity Enhancement: Core Scientific has completed a $500 million loan agreement with Morgan Stanley, with a 364-day term, significantly strengthening the company's liquidity to support the expansion of its digital infrastructure platform.
- Data Center Expansion Strategy: The financing will be utilized for expanding high-density colocation infrastructure and accelerating data center development, thereby expediting project readiness timelines and enhancing the company's competitive position in the market.
- Increased Financial Flexibility: CEO Adam Sullivan stated that the additional financing capacity will enable the company to operate decisively by deploying capital to expedite project timelines, further solidifying its role as a compelling infrastructure provider.
- Earnings Snapshot: Despite reporting a fourth-quarter adjusted loss of 29 cents and a drop in sales from $94.9 million to $79.76 million, both missing market expectations, the stock has risen 61.54% over the past year, indicating strong investor confidence.
See More
CORZ Options Contract Analysis and Investment Opportunities
- Put Option Appeal: The current bid for the $13.50 put option is 76 cents, and if an investor sells-to-open this contract, they commit to buying shares at $13.50, effectively lowering their cost basis to $12.74, which is approximately a 13% discount from the current price of $15.60, making it attractive for those interested in CORZ.
- Yield Potential Analysis: Should the put option expire worthless, it would yield a 5.63% return on the cash commitment, or an annualized 41.13%, referred to as YieldBoost, highlighting the strategy's potential appeal.
- Call Option Returns: The $17.00 call option has a current bid of $1.13, and if an investor buys CORZ shares at $15.60 and sells this call, they could achieve a total return of 16.22% if the stock is called away at expiration, showcasing the potential profitability of this strategy.
- Risk and Reward Assessment: Given that the $17.00 strike price represents a 9% premium over the current stock price, with a 54% chance of the call option expiring worthless, investors could retain both their shares and the premium collected, further enhancing their investment returns.
See More
Morgan Stanley Expands Bitcoin ETF and Loan Facility
- Bitcoin ETF Filing: On March 4, Morgan Stanley filed an amended Bitcoin ETF application with the SEC, naming Coinbase Custody and Bank of New York Mellon as custody partners, indicating aggressive expansion in the crypto space, with the Trust passively tracking Bitcoin's price to avoid speculation.
- Loan Agreement Details: Morgan Stanley provided Core Scientific with a $500 million loan facility, which can be extended to $1 billion, with an interest rate of SOFR plus 250 basis points, aimed at funding real property acquisitions and energy contracts, thereby enhancing the company's financial flexibility.
- Strategic Shift: Core Scientific is pivoting from Bitcoin mining to high-density colocation services for AI clients, expecting to monetize most of its Bitcoin reserves by 2026 to support this transition, currently holding 2,537 BTC valued at $222 million.
- Market Outlook: In January, Core Scientific sold over 1,900 BTC for approximately $175 million, leaving around 630 BTC, with the CEO stating that Bitcoin mining is now in a “runoff” phase, primarily maintaining operations to meet minimum power commitments while focusing on AI-related business.
See More
CORE SCIENTIFIC INC - TERM LOAN FACILITY EXPIRES 364 DAYS POST-CLOSING DATE - SEC FILING
- Core Scientific Loan Facility: The Core Scientific loan facility has matured 364 days after its closing date.
- SEC Filing: This development has been documented in a filing with the Securities and Exchange Commission (SEC).
See More
CORE SCIENTIFIC INC SECURES $500 MILLION SENIOR LOAN FACILITY THROUGH CREDIT AGREEMENT - SEC FILING
Loan Facility Announcement: Core Scientific has secured a senior secured loan facility amounting to $500 million.
Purpose of the Loan: The loan is intended to provide financial support for the company's operations and growth initiatives.
See More
CORE SCIENTIFIC INC SECURES LOAN FACILITY CREDIT AGREEMENT WITH MORGAN STANLEY SENIOR FUNDING ON MARCH 4 - SEC FILING
Core Scientific's Loan Facility: Core Scientific has entered into a loan facility agreement with Morgan Stanley Senior Funding to secure additional funding.
Financial Strategy: This agreement is part of Core Scientific's strategy to enhance its financial position and support its operations amidst market challenges.
See More
Core Scientific Secures $500 Million Loan Facility to Expand Infrastructure
- Liquidity Enhancement: Core Scientific has completed a $500 million loan agreement with Morgan Stanley, with a 364-day term, significantly strengthening the company's liquidity to support the expansion of its digital infrastructure platform.
- Data Center Expansion Strategy: The financing will be utilized for expanding high-density colocation infrastructure and accelerating data center development, thereby expediting project readiness timelines and enhancing the company's competitive position in the market.
- Increased Financial Flexibility: CEO Adam Sullivan stated that the additional financing capacity will enable the company to operate decisively by deploying capital to expedite project timelines, further solidifying its role as a compelling infrastructure provider.
- Earnings Snapshot: Despite reporting a fourth-quarter adjusted loss of 29 cents and a drop in sales from $94.9 million to $79.76 million, both missing market expectations, the stock has risen 61.54% over the past year, indicating strong investor confidence.
See More
CORZ Options Contract Analysis and Investment Opportunities
- Put Option Appeal: The current bid for the $13.50 put option is 76 cents, and if an investor sells-to-open this contract, they commit to buying shares at $13.50, effectively lowering their cost basis to $12.74, which is approximately a 13% discount from the current price of $15.60, making it attractive for those interested in CORZ.
- Yield Potential Analysis: Should the put option expire worthless, it would yield a 5.63% return on the cash commitment, or an annualized 41.13%, referred to as YieldBoost, highlighting the strategy's potential appeal.
- Call Option Returns: The $17.00 call option has a current bid of $1.13, and if an investor buys CORZ shares at $15.60 and sells this call, they could achieve a total return of 16.22% if the stock is called away at expiration, showcasing the potential profitability of this strategy.
- Risk and Reward Assessment: Given that the $17.00 strike price represents a 9% premium over the current stock price, with a 54% chance of the call option expiring worthless, investors could retain both their shares and the premium collected, further enhancing their investment returns.
See More
Morgan Stanley Expands Bitcoin ETF and Loan Facility
- Bitcoin ETF Filing: On March 4, Morgan Stanley filed an amended Bitcoin ETF application with the SEC, naming Coinbase Custody and Bank of New York Mellon as custody partners, indicating aggressive expansion in the crypto space, with the Trust passively tracking Bitcoin's price to avoid speculation.
- Loan Agreement Details: Morgan Stanley provided Core Scientific with a $500 million loan facility, which can be extended to $1 billion, with an interest rate of SOFR plus 250 basis points, aimed at funding real property acquisitions and energy contracts, thereby enhancing the company's financial flexibility.
- Strategic Shift: Core Scientific is pivoting from Bitcoin mining to high-density colocation services for AI clients, expecting to monetize most of its Bitcoin reserves by 2026 to support this transition, currently holding 2,537 BTC valued at $222 million.
- Market Outlook: In January, Core Scientific sold over 1,900 BTC for approximately $175 million, leaving around 630 BTC, with the CEO stating that Bitcoin mining is now in a “runoff” phase, primarily maintaining operations to meet minimum power commitments while focusing on AI-related business.
See More
